🇺🇸 The U.S. Pancreatic Cancer Precision Medicine Market is projected to rise from US$183.61 million in 2024 to US$694.48 million by 2033, expanding at a remarkable CAGR of 15.93% 📈
This strong growth reflects the U.S. healthcare system’s shift toward data-driven oncology, emphasizing early detection, precision treatment, and improved survivorship.
🔗 Read full report: 👉 https://www.renub.com/united-s....tates-pancreatic-can
📊 #precisionmedicine #oncology #pancreaticcancer #healthcareinnovation #personalizedmedicine #cancerresearch #biotech #usmarket #renubresearch
Respect!
Kommentar
Delen
